Shares in Anthem Inc. and Cigna Corp., which agreed to a $48 billion deal in July, continued to slide Thursday after presidential candidate Hillary Clinton said mergers in the industry deserve more scrutiny.
Eli Lilly and Co. beat Wall Street’s expectations with its third-quarter profit, prompting the drugmaker to raise its full-year forecast by as much as 20 cents per share.
For the $300 billion pharmaceutical industry, the rapid growth of illegal underground marketplaces is a serious threat to profits and reputations.
The Indianapolis-based law firm opened two new offices this fall—in Dallas and Seattle—and has now added five new offices in the past 24 months, as it tries to keep up with consolidation among hospitals and doctors.
The federal penalty for having no health insurance is set to jump to $695, and the Obama administration is being urged to highlight that cold fact to help drive more sign-ups.
The Indianapolis-based firm, which sells health care-management software, said it plans to use the funds to grow its sales and marketing teams, and bolster distribution channels.
AstraZeneca Plc didn’t receive U.S. approval for a new diabetes treatment that combines two of its existing drugs. The combination would have competed with Glyxambi from Lilly.
Gov. Mike Pence cited the successes of a $1 million pilot program as reason for granting a new $3.5 million contract to Real Alternatives, a Pennsylvania-based charity.
Long-time health care executive Charles C. Miraglia was picked by the center’s board of directors to replace interim CEO Dan A. Waxman, who has been in that position since January.
William S. Gibbons Jr., Cook's vice president of of global engineering, and his 15-year-old daughter, Abbey, were killed when the plane crashed into Buffalo Mountain in eastern Tennessee.
Eli Lilly shares plunged nearly 10 percent Monday morning after it said it would stop development of evacetrapib, an experimental cholesterol drug with blockbuster potential.
Suzhou, China-based Innovent could receive payments totaling more than $1 billion if the cancer products it develops with Lilly reach certain milestones.
The safety-net hospital system in Indianapolis will create the Center for Brain Care Innovation and try to use telemedicine and a digital avatar to reach as many as 150,000 Hoosiers and 10 million patients outside Indiana by 2030.
Spending on prescription drugs has soared 451 percent this year at Indianapolis-based MDwise as new drugs for hepatitis C and cancer soar above $100,000 per patient.
Patients’ anger over high deductibles and high drug prices is spurring presidential candidates to respond—even as the actual prices of health care services are growing slower than at any time since 1990.
Bryan Mills, CEO of the Community Health Network hospital system, said a recent pickup in health care construction could slow down if providers can successfully care for patients remotely via the Internet and phones.
American Senior Communities has fired its chief operating officer and accepted the resignation of its chief financial officer—17 days after an FBI raid of its offices and the home of its former CEO James Burkhart.
A 22-page timeline of events leading up to the $54 billion merger agreement between Anthem and Cigna shows that company executives fell in love early, but the Anthem board made them break up and they chased other lovers. But in the end, they were each other’s only choice.
Puerto Rico officials are looking to replace an expiring tax with a new levy to draw much-needed revenue from the world’s best-selling medications while seeking to avoid driving U.S. manufacturers such as Eli Lilly and Co. from the commonwealth.
The university will lead a consortium of eight institutions that will use the money to create a system of coaches embedded in medical practices.
